Medical News

RSS

New discovery may lead to targeted treatment for copper metabolism disorders

Individuals with defects in copper metabolism may soon have more targeted treatment options thanks to a discovery by a research team led by Dr. Vishal Gohil of Texas A&M AgriLife Research in College Station.

31 Jul 2018

New guidelines provide framework for responding to drug shortages and to improve patient care

Healthcare teams in patient care settings can develop policies and procedures to minimize the impact of drug shortages by incorporating new guidelines published today by ASHP (American Society of Health-System Pharmacists).

31 Jul 2018

Women & Infants Hospital introduces new technology for physicians to mark and find breast lesions

Thanks to better imaging and increased screening, many breast lumps today are detected at the earliest stages, often when lesions are small and hard to locate during surgery.

31 Jul 2018

LSTM to lead new multinational project on sepsis research in Africa

LSTM is to lead a new multinational project on sepsis following a £2 million award from the National Institute of Health Research.

31 Jul 2018

UVA heart failure program slashes mortality rate and reduces costs, study finds

A University of Virginia Health System program that provides follow-up care for heart failure patients after they leave the hospital significantly improves survival and other outcomes while saving money, a new study finds.

31 Jul 2018

Glaucoma Research Foundation-funded research makes breakthrough in treatment of glaucoma

Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers, led by Adriana Di Polo, PhD, at University of Montreal, have made a major breakthrough in the treatment of glaucoma.

31 Jul 2018

European Commission approves Pfizer’s first oncology biosimilar

Pfizer Inc. today announced the European Commission has approved TRAZIMERA, a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

31 Jul 2018

Inhibiting a protein could enhance effectiveness of cancer immunotherapies

Researchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy in the Johns Hopkins Kimmel Cancer Center discovered inhibiting a previously known protein could reduce tumor burdens and enhance the effectiveness of immunotherapy treatments.

31 Jul 2018

Ortho Clinical Diagnostics receives FDA approval for two hepatitis B assays

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, has received approval from the U.S. Food and Drug Administration for Ortho's VITROS Immunodiagnostic Products HBeAg Assay and the VITROS Immunodiagnostic Products Anti-HBe Assay for use on Ortho's VITROS 3600 Immunodiagnostic System and Ortho's VITROS 5600 Integrated System.

31 Jul 2018

Long-term heat therapy may increase mitochondrial function in muscles

A new study finds that long-term heat therapy may increase mitochondrial function in the muscles. The discovery could lead to new treatments for people with chronic illness or disease. The study, the first of its kind in humans - is published ahead of print in the Journal of Applied Physiology.

31 Jul 2018

Mortality rate increases during tropical nights in Barcelona

A statistical analysis of the effects of very hot nights on the death rate in Barcelona's environment reveals that, during these nocturnal periods, more deaths occur due to natural, respiratory and cardiovascular causes.

31 Jul 2018

Study: Obese patients have high risk of infection and death after colon surgery

Do obese patients have a higher risk of infection and dying after colon surgery? In a study published in the August issue of Diseases of the Colon & Rectum, investigators from the University of Alabama at Birmingham sought to answer this question.

31 Jul 2018

Cancer cells proliferate less when their internal pH is lowered, study shows

A new computational model has allowed researchers to identify new therapeutic targets that can attack cancer cells by lowering their intracellular pH. The study, which is the result of collaboration between IRB Barcelona, the Moffitt Cancer Center, and the University of Maryland, has been published in Nature Communications.

31 Jul 2018